Arquivamento definitivo - Art. 33 da LPI
#11.1.1
04/18/2023
RPI 2728
Application data
Number
112021007082Type
Filing
Publication
PCT
US2019057257 The application was abandoned: examination was not requested within the 36 months following the 10/21/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/18/2023. We update with every new RPI gazette, published weekly.
Applicants
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
GB
Inventors
C. E. (pessoa física)
US
E. P. (pessoa física)
US
J. K. (pessoa física)
US
P. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/748,595 · 10/22/2018
US
62/807,897 · 02/20/2019
US
62/837,385 · 04/23/2019
US
62/895,229 · 09/03/2019
US
62/902,444 · 09/19/2019
Abstract
DOSAGEM.A presente invenção refere-se a um método para o tratamento de câncer, que compreende administrar ao humano uma proteína de ligação a ICOS, ou uma porção de ligação ao antígeno da mesma, a uma dose entre aproximadamente 0,08 mg e 240 mg.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
04/18/2023
RPI 2728
#11.1
01/31/2023
RPI 2717
#1.3
08/03/2021
RPI 2639
#1.1
04/27/2021
RPI 2625
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.